Transcatheter aortic valve implantation: A single-center experience of 300 cases

Israel Medical Association Journal

Volumn 15, Issue 10, 2013, Pages 613-616

  Finkelstein, Ariel ^a,b   Birati, Edo Y ^a,b   Abramowitz, Yigal ^a,b   Steinvil, Arie ^a,b   Sheinberg, Nechama ^a,b   Biner, Simon ^a,b   Bazan, Shmuel ^a,b   Gal, Yanai Ben ^a,b   Halkin, Amir ^a,b   Arbel, Yaron ^a,b   Ben Assa, Eyal ^a,b   Leshem Rubinow, Eran ^a,b   Keren, Gad ^a,b   Banai, Shmuel ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aortic stenosis; Bioprosthetic heart valves; Interventional cardiology; Transcatheter aortic valve implantation (TAVI); Valvular heart disease

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTOGRAPHY; ARTICLE; ATRIOVENTRICULAR BLOCK; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; FEMALE; FEMORAL ANGIOGRAPHY; FOLLOW UP; HEART TAMPONADE; HOSPITALIZATION; HUMAN; IMPLANTED HEART PACEMAKER; MAJOR CLINICAL STUDY; MALE; MORTALITY; SEPSIS; STENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; COHORT STUDIES; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 84887132139     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ben-Dor I, Pichard AD, Satler LF, et al. Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement. Am J Cardiol 2010; 105: 857-61.
2. Coeytaux RR, Williams JW Jr, Gray RN, Wang A. Percutaneous heart valve replacement for aortic stenosis: state of the evidence. Ann Intern Med 2010; 153: 314-24.
3. Gilard M, Eltchaninoff H, Iung B, et al; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366: 1705-15.
4. Danenberg H, Finkelstein A, Kornowski R, et al. Percutaneous implantation of the self-expandable CoreValve for high risk patients with severe aortic valve stenosis: early Israeli experience. IMAJ 2010; 12: 468-71.
5. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) Registry. Eur Heart J 2011; 32: 191-7.
6. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-90.
7. Tomas M, Schymik G, Walther T, et al. Tirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010; 122: 62-9.
8. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
9. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 2011; 32: 205-17.
10. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607.
11. Dworakowski R, MacCarthy PA, Monaghan M, et al. Transcatheter aortic valve implantation for severe aortic stenosis - a new paradigm for multidisciplinary intervention: a prospective cohort study. Am Heart J 2010; 160: 237-43.